Related Experiment Videos
Osteoporosis in relation to menopause.
1Department of Obstetrics & Gynaecology, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074.
Annals of the Academy of Medicine, Singapore
|March 12, 2002
Summary
Postmenopausal osteoporosis is a growing concern in Singapore due to an aging population. This review covers current treatments and prevention strategies for osteoporosis and fractures.
Area of Science:
- Gerontology
- Endocrinology
- Orthopedics
Background:
- Singapore's aging population presents a growing challenge of postmenopausal osteoporosis and fractures.
- Estrogen replacement therapy has been a traditional treatment for postmenopausal issues, including osteoporosis.
Purpose of the Study:
- To review the evidence for selecting appropriate agents for postmenopausal osteoporosis.
- To outline strategies for the prevention and treatment of postmenopausal osteoporosis.
Main Methods:
- Literature review of current therapeutic options.
- Analysis of evidence for osteoporosis management.
Main Results:
- Multiple potent agents beyond estrogen replacement are available, including bisphosphonates, calcitonin, and selective estrogen receptor modulators.
- A range of therapeutic options enriches the management of postmenopausal osteoporosis.
Conclusions:
- Effective strategies exist for preventing and treating postmenopausal osteoporosis.
- The choice of agent depends on individual patient needs and evidence-based recommendations.